These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38827807)

  • 1. Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach.
    Pahlavan Y; Yeganeh O; Asghariazar V; Karami C
    Future Sci OA; 2024; 10(1):FSO939. PubMed ID: 38827807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Adam KM
    Trop Dis Travel Med Vaccines; 2021 Jul; 7(1):22. PubMed ID: 34238372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spike protein-based epitopes predicted against SARS-CoV-2 through literature mining.
    Li W; Li L; Sun T; He Y; Liu G; Xiao Z; Fan Y; Zhang J
    Med Nov Technol Devices; 2020 Dec; 8():100048. PubMed ID: 33052325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
    Anand R; Biswal S; Bhatt R; Tiwary BN
    PeerJ; 2020; 8():e9855. PubMed ID: 33062414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y; Li J; Du L; Yan X; Hu G; Zhou Y; Jiang S
    Vaccine; 2006 Jun; 24(26):5498-508. PubMed ID: 16725238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
    Khairkhah N; Aghasadeghi MR; Namvar A; Bolhassani A
    PLoS One; 2020; 15(10):e0240577. PubMed ID: 33057358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immunological Profiles of SARS-CoV-2 Variants in the COVID-19 Pandemic Trends: An Immunoinformatics Approach.
    Mallavarpu Ambrose J; Priya Veeraraghavan V; Kullappan M; Chellapandiyan P; Krishna Mohan S; Manivel VA
    Antibiotics (Basel); 2021 May; 10(5):. PubMed ID: 34066389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatics analysis of Brucella melitensis to approach a suitable vaccine against brucellosis.
    Hashemzadeh P; Nezhad SA; Khoshkhabar H
    J Genet Eng Biotechnol; 2023 Nov; 21(1):152. PubMed ID: 38019359
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mohammadzadeh Hosseini Moghri SAH; Ranjbar M; Hassannia H; Khakdan F
    J Biomol Struct Dyn; 2023; 41(16):7603-7615. PubMed ID: 36124826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of multi-epitope vaccine candidate against SARS-CoV-2: a
    Abraham Peele K; Srihansa T; Krupanidhi S; Ayyagari VS; Venkateswarulu TC
    J Biomol Struct Dyn; 2021 Jul; 39(10):3793-3801. PubMed ID: 32419646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based on an Immunoinformatics Approach.
    Farhani I; Yamchi A; Madanchi H; Khazaei V; Behrouzikhah M; Abbasi H; Salehi M; Moradi N; Sanami S
    Curr Comput Aided Drug Des; 2024; 20(3):274-290. PubMed ID: 37309762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay.
    Polyiam K; Phoolcharoen W; Butkhot N; Srisaowakarn C; Thitithanyanont A; Auewarakul P; Hoonsuwan T; Ruengjitchatchawalya M; Mekvichitsaeng P; Roshorm YM
    Sci Rep; 2021 Oct; 11(1):20383. PubMed ID: 34650130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
    Sanami S; Alizadeh M; Nosrati M; Dehkordi KA; Azadegan-Dehkordi F; Tahmasebian S; Nosrati H; Arjmand MH; Ghasemi-Dehnoo M; Rafiei A; Bagheri N
    Comput Biol Med; 2021 Jun; 133():104390. PubMed ID: 33895459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.